News Detail
Home / News / Company News / Goldsite Diagnostics at MEDICA 2026 | World Premiere of GSH-120

Goldsite Diagnostics at MEDICA 2026 | World Premiere of GSH-120

Author: Site Editor     Publish Time: 2026-11-18      Origin: Site

Inquire

facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button

Goldsite Diagnostics at MEDICA 2026 | World Premiere of GSH-120
 

COMPANY NEWS

GSH-120 Debuts at MEDICA 2026

High-Throughput Ion-Exchange HPLC
HbA1c Analyzer

 

Hall 1 · Stand B56  |  16–19 November 2026  |  Messe Düsseldorf, Germany

120

TESTS / HOUR

30 s

PER TEST

3 µL

WHOLE BLOOD

≤1%

CV PRECISION

GSH-120 HPLC HbA1c Analyzer World Premiere

GSH-120 HPLC HbA1c Analyzer World Premiere

Düsseldorf, Germany — November 2026

At MEDICA 2026 (16–19 November 2026, Messe Düsseldorf), Goldsite Diagnostics is proud to present the world premiere of the GSH-120 — our new high-throughput ion-exchange HPLC HbA1c analyzer engineered for high-volume laboratories. Showcased at Hall 1 · Stand B56 alongside our complete HPLC HbA1c portfolio (GSH-50 / GSH-60 / GSH-120) and broader diagnostic solutions, the GSH-120 has been a focal point of the exhibition.

GSH-120 HPLC HbA1c Analyzer World Premiere

GSH-120 HPLC HbA1c Analyzer World Premiere

01 — The Booth

Strong Reception at Hall 1 · Stand B56

Throughout the fair, laboratory directors, endocrinology specialists, and global distributors have gathered at Stand B56 for live demonstrations of the GSH-120. Visitors consistently praised how the system bridges the gap between reference-grade analytical quality and high-throughput laboratory practicality — highlighting its 30-second test cycle, effortless cap-piercing workflow, and scalable automation as key differentiators for modern clinical laboratories.

Goldsite Diagnostics booth at MEDICA 2026, Hall 1 Stand B56

Visitors explore the GSH-120 at the Goldsite Diagnostics stand, Hall 1 · Stand B56.

02 — Workflow

Engineered for Superior Laboratory Workflow

Every detail of the GSH-120 is purpose-built to eliminate manual bottlenecks and maximize daily lab productivity.

High Throughput with Priority STAT Access

Delivering up to 120 tests per hour (30 seconds per test), the analyzer features a 110-sample continuous loading track and a dedicated STAT position, ensuring urgent samples are processed immediately without interrupting routine batch runs.

True Walk-Away Micro-Sampling

Requiring just 3 µL of whole blood, the GSH-120 performs direct cap-piercing with no manual uncapping or sample pretreatment. Automated barcode scanning, sample mixing, and simultaneous recognition of primary tubes and dilution cups further reduce hands-on time.

Intuitive Operation & Seamless Connectivity

A 10.3-inch ergonomic tilted touchscreen, bidirectional LIS connectivity, and a built-in thermal printer streamline data management and minimize operator training requirements.

Scalable Automation & Low-Maintenance Design

Built to grow with laboratory demand, the GSH-120 supports multi-unit cascading and direct connection to laboratory automation tracks. Internally, a parallel dual-pump high-pressure fluidic system, smart column-washing cycles, and automated daily maintenance reduce clogging risks and extend column and filter lifespan.

GSH-120 HPLC HbA1c Analyzer World Premiere

Visitors on the Goldsite Diagnostics stand, Hall 1 · Stand B56, at MEDICA 2026

03 — Clinical Value

Precision Beyond Routine Numbers

While speed drives laboratory efficiency, analytical accuracy drives clinical confidence. Powered by the JCTLM reference method — ion-exchange high-performance liquid chromatography (HPLC) — the GSH-120 delivers CV ≤ 1% precision across a wide 2.8%–18.4% measuring range.

Method Ion-exchange HPLC (JCTLM reference method)
Measuring range 2.8% – 18.4%
Precision CV ≤ 1%
Reported per run NGSP & IFCC units, HbF, eAG

Variant-Proof Accuracy for Diverse Populations

With selectable standard and variant/thalassemia modes, the GSH-120 cleanly separates common hemoglobin variants (HbE, HbD, HbS, and HbC). This prevents variant interference that can cause falsely elevated or depressed HbA1c readings, safeguarding accurate diagnosis and treatment decisions in diverse and thalassemia-prevalent patient populations.

Comprehensive, Guideline-Aligned Reporting

In a single 30-second run, the system outputs both NGSP and IFCC units alongside HbF and estimated average glucose (eAG) — giving clinicians complete, standardized glycemic insights for diabetes screening, diagnosis, and long-term therapeutic monitoring.

Goldsite Diagnostics full HPLC HbA1c lineup.

Full GSH-50 / GSH-60 / GSH-120 HPLC HbA1c lineup.

04 — Visit Us

Experience the GSH-120 Firsthand

We invite laboratory professionals, distributors, and partners to visit Hall 1, Stand B56 through 19 November 2026 to experience the GSH-120 firsthand and explore our full GSH-50 / GSH-60 / GSH-120 HPLC HbA1c lineup.

Stand Hall 1, Stand B56
Dates 16–19 November 2026
Venue Messe Düsseldorf, Germany

GOLDSITE DIAGNOSTICS INC.

Your Path to Accurate Diagnostics.
en.goldsite.com.cn

See Goldsite's latest trend on social media.

Copyright © 1999- 2026 Goldsite Diagnostics Inc., All rights reserved.  Sitemap